Source:http://linkedlifedata.com/resource/pubmed/id/11274219
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions |
umls-concept:C0029266,
umls-concept:C0031676,
umls-concept:C0033684,
umls-concept:C0037083,
umls-concept:C0061928,
umls-concept:C0086376,
umls-concept:C0265341,
umls-concept:C0450429,
umls-concept:C1167622,
umls-concept:C1537044,
umls-concept:C1704735,
umls-concept:C1710082,
umls-concept:C1880177,
umls-concept:C2698694
|
pubmed:issue |
23
|
pubmed:dateCreated |
2001-6-4
|
pubmed:abstractText |
Regulator of G protein signaling (RGS) proteins must bind membranes in an orientation that permits the protein-protein interactions necessary for regulatory activity. RGS4 binds to phospholipid surfaces in a slow, multistep process that leads to maximal GTPase-activating protein (GAP) activity. When RGS4 is added to phospholipid vesicles that contain m2 or m1 muscarinic receptor and G(i), G(z), or G(q), GAP activity increases approximately 3-fold over 4 h at 30 degrees C and more slowly at 20 degrees C. This increase in GAP activity is preceded by several other events that suggest that, after binding, optimal interaction with G protein and receptor requires reorientation of RGS4 on the membrane surface, a conformational change, or both. Binding of RGS4 is initially reversible but becomes irreversible within 5 min. Onset of irreversibility parallels initial quenching of tryptophan fluorescence (t(12) approximately 30 s). Further quenching occurs after binding has become irreversible (t(12) approximately 6 min) but is complete well before maximal GAP activity is attained. These processes all appear to be energetically driven by the amphipathic N-terminal domain of RGS4 and are accelerated by palmitoylation of cysteine residues in this region. The RGS4 N-terminal domain confers similar membrane binding behavior on the RGS domains of either RGS10 or RGSZ1.
|
pubmed:grant | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Jun
|
pubmed:issn |
0021-9258
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:day |
8
|
pubmed:volume |
276
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
20160-6
|
pubmed:dateRevised |
2007-11-14
|
pubmed:meshHeading |
pubmed-meshheading:11274219-Animals,
pubmed-meshheading:11274219-GTPase-Activating Proteins,
pubmed-meshheading:11274219-Humans,
pubmed-meshheading:11274219-Lipid Bilayers,
pubmed-meshheading:11274219-Phospholipids,
pubmed-meshheading:11274219-Protein Binding,
pubmed-meshheading:11274219-RGS Proteins,
pubmed-meshheading:11274219-Rats
|
pubmed:year |
2001
|
pubmed:articleTitle |
Binding of regulator of G protein signaling (RGS) proteins to phospholipid bilayers. Contribution of location and/or orientation to Gtpase-activating protein activity.
|
pubmed:affiliation |
Department of Pharmacology, University of Texas Southwestern Medical Center, Dallas, Texas 75390-9041, USA.
|
pubmed:publicationType |
Journal Article,
Research Support, U.S. Gov't, P.H.S.,
Research Support, Non-U.S. Gov't
|